Firm fixed price award office of the commissioner (OC) - patent legal services COR: octavis lampkin

Active Awarded Last action

Contract number
75F40124F19002
Awardee
Awarding agency
Obligated
$2,050,000

Award facts

Contract value 54% obligated
  • $2,050,000.00 Current, with exercised options
  • $3,766,617.00 Potential, with all options
Completion date 47% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541110 Offices of Lawyers
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 · Time and materials award $650,000
Exercise an Option P00002 $650,000
Other Administrative Action P00001 · Time and materials award office of the commissioner (OC) - patent legal services COR: octavis lampkin $0
Original award $750,000

About this award

The Food and Drug Administration issued a delivery order to Klarquist Sparkman, LLP on May 3, 2024, with a ceiling value of $3,766,617 and an ultimate completion date of July 29, 2029. The order is issued under the FDA's single-award patent legal services IDIQ ($5,010,000 through July 2027) and is priced on a firm fixed price basis, with time and materials components.

Place of performance is Silver Spring, MD. The order funds patent legal services for the Office of the Commissioner, including patent application drafting and filing, patent office action responses, conflict-of-interest clearances, Patent Cooperation Treaty filings, and patent portfolio management for inventions arising from federally funded research.

Service Contract Inventory reporting shows $309,000 invoiced across FY2024–FY2025 (FY2024: $9,000 on 13 contractor hours at $680.13/hr; FY2025: $300,000 on 0.1 FTEs). Klarquist Sparkman self-performed all reported hours with no subcontractors.

Quick answers

Who was awarded contract 75F40124F19002?

75F40124F19002 was awarded to Klarquist Sparkman, LLP by Food and Drug Administration (Department of Health and Human Services) on May 3, 2024.

How much is contract 75F40124F19002 worth?

The government has obligated $2,050,000 on 75F40124F19002. Its potential value, with all options, is $3,766,617.

Is contract 75F40124F19002 an order under another contract?

Yes. 75F40124F19002 is a delivery order under 75F40122D00020, an indefinite delivery contract.

Was contract 75F40124F19002 competed?

The extent of competition for 75F40124F19002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award